CombiMatrix's Pre-Implantation Genetic Screening Approval Highlights Today's Pre-Market Biotech Roundup

By: via Benzinga
CombiMatrix Corp (NASDAQ: CBMX): Granted approval for pre-implantation genetic screening and conditional approval from NYS Department of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.